.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Drug patents in 130+ countries
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Covington
Federal Trade Commission
Colorcon
Chinese Patent Office
Medtronic
Argus Health
Daiichi Sankyo
Express Scripts
Teva

Generated: June 28, 2017

DrugPatentWatch Database Preview

COMPOUND 65 Drug Profile

« Back to Dashboard

What is the patent landscape for Compound 65, and what generic Compound 65 alternatives are available?

Compound 65 is a drug marketed by Alra and is included in one NDA.

The generic ingredient in COMPOUND 65 is aspirin; caffeine; propoxyphene hydrochloride. There are twenty-one drug master file entries for this compound. Additional details are available on the aspirin; caffeine; propoxyphene hydrochloride profile page.

Summary for Tradename: COMPOUND 65

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list76
Clinical Trials: see list1,131
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:COMPOUND 65 at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Alra
COMPOUND 65
aspirin; caffeine; propoxyphene hydrochloride
CAPSULE;ORAL084553-002Aug 17, 1983DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Daiichi Sankyo
McKinsey
Baxter
Fish and Richardson
McKesson
Novartis
Citi
Boehringer Ingelheim
Chubb
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot